Flexible Spending Account or Arrangement (FSA)

A Flexible Spending Account or Arrangement (FSA) is a type of employee benefit plan that allows employees to set aside a portion of their pre-tax salary to pay for qualified healthcare expenses. These funds can be used to pay for a wide range of out-of-pocket healthcare costs, including deductibles, co-payments, and prescription medications.

Here are some key features of a Flexible Spending Account or Arrangement (FSA):

  • Pre-tax contributions: FSAs allow employees to contribute a portion of their pre-tax salary to the account, which reduces their taxable income and can result in lower overall taxes.

  • Use-it-or-lose-it rule: Employees must use the funds in their FSA by the end of the plan year, or they will forfeit any unused funds. Some employers may allow a grace period or the ability to roll over a portion of the unused funds to the following plan year.

  • Qualified expenses: FSAs can be used to pay for a wide range of qualified healthcare expenses, including deductibles, co-payments, prescription medications, and other out-of-pocket costs.

  • Employer contributions: Employers may choose to contribute to their employees' FSA accounts, which can help to offset some of the out-of-pocket healthcare costs.

  • Limited annual contribution: The annual contribution limit for FSAs is set by the IRS and is subject to change each year. For 2022, the limit is $2,850 per employee.

Example:

An example of an FSA in action is an employee who contributes $2,000 to their FSA for the plan year. Throughout the year, they use the funds to pay for qualified healthcare expenses, including co-payments, prescription medications, and medical supplies. Because the contributions were made on a pre-tax basis, the employee's taxable income is reduced by $2,000, which can result in a lower overall tax bill. At the end of the plan year, any unused funds are forfeited, and the employee must decide whether to contribute to the FSA again for the following year.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.